-
Archives
- June 2018
- February 2018
- May 2017
- January 2017
- December 2016
- November 2016
- October 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- August 2015
- July 2015
- June 2015
- March 2015
- February 2015
- September 2014
- July 2014
- January 2014
- November 2013
- July 2013
- June 2013
- April 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- June 2012
- May 2012
- March 2012
- December 2011
- November 2011
- July 2011
- March 2011
-
Meta
Category Archives: AHPPI News
Cardiac Safety – the industry perspective
Dr Boaz Mendzelevski, BioClinica Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link). This year marks the 10th anniversary of the introduction of the ICH E14 guideline which was introduced to provide … Continue reading
Comments Off on Cardiac Safety – the industry perspective
Introduction to EUFEMED & European Training Course in Human Pharmacology
Dr Jörg Täubel, EUFEMED Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link). Jörg explained that the AHPPI is a founder member of EUFEMED, which was born after a long gestation on 20 … Continue reading
Comments Off on Introduction to EUFEMED & European Training Course in Human Pharmacology
Use of a Novel Risk Rating System in Early Clinical Trials
Dr Brian Leaker, Respiratory Clinical Trials. Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link). Brian outlined the structure of his unit and, in particular, the research side of the operation. The … Continue reading
Comments Off on Use of a Novel Risk Rating System in Early Clinical Trials
We’ve setup a company page on Linkedin
To complement the private group that we have had running on Linkedin for some time, we have now opened up a public ‘company page’. You may follow us there!
Comments Off on We’ve setup a company page on Linkedin
Risk Management for Early Trials in Biologicals
Dr Richard FitzGerald, Royal Liverpool University Hospital. Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link). Starting with TeGenero and referring to subsequent guidelines for Phase I trials from such bodies as … Continue reading
Risk Management in a CRO Phase I Unit
Dr John Lambert, PAREXEL. Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link). John introduced his talk by describing the changing face of early phase clinical trials and the potential for ‘risk’ in … Continue reading
AVAILABLE NOW: 2015 AHPPI Conference Presentations
Thursday 29-October-2015 Academy of Medical Sciences, London The presentations from this year’s AHPPI Annual Meeting have been uploaded to the conference page (link).
Comments Off on AVAILABLE NOW: 2015 AHPPI Conference Presentations
AHPPI Annual Meeting – Programme 29-Oct-2015
Thursday 29th October 2015 Academy of Medical Sciences, London We are pleased to announce the programme for this year’s AHPPI Annual Meeting (link). There will be a range of speakers from commercial and academic backgrounds delivering presentations on a variety … Continue reading
Comments Off on AHPPI Annual Meeting – Programme 29-Oct-2015
Risk Management in Early Phase Clinical Trials
Thursday 29th October 2015 Academy of Medical Sciences, London We are pleased to announce this year’s AHPPI Annual Meeting. There will be a range of speakers from commercial and academic backgrounds delivering presentations on a variety of issues within this … Continue reading
Comments Off on Risk Management in Early Phase Clinical Trials
Faculty conversation: TQT study – this is the end!
Recently, the FDA, other regulatory bodies, and pharmaceutical companies have been exploring options to replace TQTs with preclinical testing or with data collected during standard Phase I trials. Join colleagues from the FPM and also the British Pharmacological Society and … Continue reading
Comments Off on Faculty conversation: TQT study – this is the end!